A micro-RNA expression signature for human NAFLD progression.

Area of Science:

• Hepatology
• Molecular Biology
• Genomics

Background:

• Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum from simple fatty liver to cirrhosis and hepatocellular carcinoma.
• Understanding NAFLD etiology is limited by disease complexity and challenges in liver sampling.
• Investigating microRNA (miRNA) expression in obese subjects undergoing bariatric surgery offers insights into disease progression.

Purpose of the Study:

• To identify altered microRNA (miRNA) expression profiles associated with nonalcoholic fatty liver disease (NAFLD) severity.
• To explore the potential of specific miRNAs as biomarkers for NAFLD progression.
• To examine miRNA expression patterns in relation to hepatocellular carcinoma (HCC).

Main Methods:

• Next-generation RNA sequencing of liver biopsies from class III obese individuals.
• Comparison of RNA expression profiles for microRNAs (miRNAs), transfer RNAs (tRNAs), and small RNAs.
• Stratification of 36 liver biopsy specimens based on NAFLD disease severity.

Main Results:

• Three miRNAs (miR-301a-3p, miR-34a-5p, and miR-375) showed differential regulation with NAFLD progression, validated by RT-PCR.
• No significant association was found between tRNAs or miscellaneous small RNAs and NAFLD severity.
• Similar patterns of miR-301a and miR-375 dysregulation were observed in hepatocellular carcinoma (HCC) samples from The Cancer Genome Atlas (TCGA).

Conclusions:

• Altered hepatic miRNA expression patterns are associated with NAFLD severity and may influence lipid and carbohydrate metabolism.
• The identified miRNAs (miR-301a-3p, miR-34a-5p, miR-375) show potential as biomarkers for assessing NAFLD severity.
• Sustained miRNA expression patterns may contribute to the progression from NAFLD to HCC.